• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

    3.970 +0.030 (+0.76%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 287,680
    Open 3.950
    Bid (Size) 3.970 (200)
    Ask (Size) 3.980 (4,200)
    Prev. Close 3.940
    Today's Range 3.920 - 4.025
    52wk Range 3.745 - 9.159
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire

    Performance

    YTD
    -40.6%
    -40.6%
    1 Month
    -8.7%
    -8.7%
    3 Month
    -19.0%
    -19.0%
    6 Month
    -33.8%
    -33.8%
    1 Year
    -50.7%
    -50.7%

    More News

    Read More
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub
    Via MarketMinute
    Topics Economy Initial Public Offering
    News headline image
    Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Strengthens Board of Directors with New Appointments
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    4 Analysts Assess Bicycle Therapeutics: What You Need To Know ↗
    Via Benzinga
    News headline image
    Bicycle (BCYC) Q2 Revenue Falls 69% ↗
    Via The Motley Fool
    Topics Intellectual Property
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews ↗
    Via Benzinga
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting
    From Bicycle Therapeutics
    Via Business Wire
    News headline image
    Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    A Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 Analysts ↗
    Via Benzinga
    News headline image
    Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
    From Bicycle Therapeutics plc
    Via Business Wire
    News headline image
    Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025
    From Bicycle Therapeutics plc
    Via Business Wire

    Frequently Asked Questions

    Is Bicycle Therapeutics plc - American Depositary Shares publicly traded?
    Yes, Bicycle Therapeutics plc - American Depositary Shares is publicly traded.
    What exchange does Bicycle Therapeutics plc - American Depositary Shares trade on?
    Bicycle Therapeutics plc - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Bicycle Therapeutics plc - American Depositary Shares?
    The ticker symbol for Bicycle Therapeutics plc - American Depositary Shares is BCYC on the Nasdaq Stock Market
    What is the current price of Bicycle Therapeutics plc - American Depositary Shares?
    The current price of Bicycle Therapeutics plc - American Depositary Shares is 3.970
    When was Bicycle Therapeutics plc - American Depositary Shares last traded?
    The last trade of Bicycle Therapeutics plc - American Depositary Shares was at 08/05/26 04:00 PM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.